0.017510 0.000000 0.000000 0.000000 0.016356 0.000000 0.000000 0.000000 0.030184 0.00000 0.00000 0.00000 Harata, K. Muraki, M. Jigami, Y. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 4 90.00 90.00 90.00 57.110 61.140 33.130 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK J.Mol.Biol. JMOBAK 0070 0022-2836 233 524 535 10.1006/jmbi.1993.1529 8105095 Role of Arg115 in the catalytic action of human lysozyme. X-ray structure of His115 and Glu115 mutants. 1993 IX Eur.J.Biochem. EJBCAI 0262 0014-2956 179 573 A Structural Requirement in the Subsite F of Lysozyme. The Role of Arginine 115 in Human Lysozyme Revealed by Site-Directed Mutagenesis 1989 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 x-ray 1 1.0 14701.646 HUMAN LYSOZYME 3.2.1.17 1 man polymer 18.015 water 72 nat water no no KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKTPGAVNACHLS CSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNHCQNRDVRQYVQGCGV KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKTPGAVNACHLS CSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNHCQNRDVRQYVQGCGV A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo sample 9606 Homo sapiens M13 1.97 37.46 pdbx_database_status struct_conf struct_conf_type repository Initial release Version format compliance Version format compliance Derived calculations Other 1 0 1993-10-31 1 1 2008-03-24 1 2 2011-07-13 1 3 2017-11-29 _pdbx_database_status.process_site Y BNL 1993-06-01 REL REL HOH water HOH 131 2 HOH HOH 131 A HOH 132 2 HOH HOH 132 A HOH 133 2 HOH HOH 133 A HOH 134 2 HOH HOH 134 A HOH 135 2 HOH HOH 135 A HOH 136 2 HOH HOH 136 A HOH 137 2 HOH HOH 137 A HOH 138 2 HOH HOH 138 A HOH 139 2 HOH HOH 139 A HOH 140 2 HOH HOH 140 A HOH 141 2 HOH HOH 141 A HOH 142 2 HOH HOH 142 A HOH 143 2 HOH HOH 143 A HOH 144 2 HOH HOH 144 A HOH 145 2 HOH HOH 145 A HOH 146 2 HOH HOH 146 A HOH 147 2 HOH HOH 147 A HOH 148 2 HOH HOH 148 A HOH 149 2 HOH HOH 149 A HOH 150 2 HOH HOH 150 A HOH 151 2 HOH HOH 151 A HOH 152 2 HOH HOH 152 A HOH 153 2 HOH HOH 153 A HOH 154 2 HOH HOH 154 A HOH 155 2 HOH HOH 155 A HOH 156 2 HOH HOH 156 A HOH 157 2 HOH HOH 157 A HOH 158 2 HOH HOH 158 A HOH 159 2 HOH HOH 159 A HOH 160 2 HOH HOH 160 A HOH 161 2 HOH HOH 161 A HOH 162 2 HOH HOH 162 A HOH 163 2 HOH HOH 163 A HOH 164 2 HOH HOH 164 A HOH 165 2 HOH HOH 165 A HOH 166 2 HOH HOH 166 A HOH 167 2 HOH HOH 167 A HOH 168 2 HOH HOH 168 A HOH 169 2 HOH HOH 169 A HOH 170 2 HOH HOH 170 A HOH 171 2 HOH HOH 171 A HOH 172 2 HOH HOH 172 A HOH 173 2 HOH HOH 173 A HOH 174 2 HOH HOH 174 A HOH 175 2 HOH HOH 175 A HOH 176 2 HOH HOH 176 A HOH 177 2 HOH HOH 177 A HOH 178 2 HOH HOH 178 A HOH 179 2 HOH HOH 179 A HOH 180 2 HOH HOH 180 A HOH 181 2 HOH HOH 181 A HOH 182 2 HOH HOH 182 A HOH 183 2 HOH HOH 183 A HOH 184 2 HOH HOH 184 A HOH 185 2 HOH HOH 185 A HOH 186 2 HOH HOH 186 A HOH 187 2 HOH HOH 187 A HOH 188 2 HOH HOH 188 A HOH 189 2 HOH HOH 189 A HOH 190 2 HOH HOH 190 A HOH 191 2 HOH HOH 191 A HOH 192 2 HOH HOH 192 A HOH 193 2 HOH HOH 193 A HOH 194 2 HOH HOH 194 A HOH 195 2 HOH HOH 195 A HOH 196 2 HOH HOH 196 A HOH 197 2 HOH HOH 197 A HOH 198 2 HOH HOH 198 A HOH 199 2 HOH HOH 199 A HOH 200 2 HOH HOH 200 A HOH 201 2 HOH HOH 201 A HOH 202 2 HOH HOH 202 A LYS 1 n 1 LYS 1 A VAL 2 n 2 VAL 2 A PHE 3 n 3 PHE 3 A GLU 4 n 4 GLU 4 A ARG 5 n 5 ARG 5 A CYS 6 n 6 CYS 6 A GLU 7 n 7 GLU 7 A LEU 8 n 8 LEU 8 A ALA 9 n 9 ALA 9 A ARG 10 n 10 ARG 10 A THR 11 n 11 THR 11 A LEU 12 n 12 LEU 12 A LYS 13 n 13 LYS 13 A ARG 14 n 14 ARG 14 A LEU 15 n 15 LEU 15 A GLY 16 n 16 GLY 16 A MET 17 n 17 MET 17 A ASP 18 n 18 ASP 18 A GLY 19 n 19 GLY 19 A TYR 20 n 20 TYR 20 A ARG 21 n 21 ARG 21 A GLY 22 n 22 GLY 22 A ILE 23 n 23 ILE 23 A SER 24 n 24 SER 24 A LEU 25 n 25 LEU 25 A ALA 26 n 26 ALA 26 A ASN 27 n 27 ASN 27 A TRP 28 n 28 TRP 28 A MET 29 n 29 MET 29 A CYS 30 n 30 CYS 30 A LEU 31 n 31 LEU 31 A ALA 32 n 32 ALA 32 A LYS 33 n 33 LYS 33 A TRP 34 n 34 TRP 34 A GLU 35 n 35 GLU 35 A SER 36 n 36 SER 36 A GLY 37 n 37 GLY 37 A TYR 38 n 38 TYR 38 A ASN 39 n 39 ASN 39 A THR 40 n 40 THR 40 A ARG 41 n 41 ARG 41 A ALA 42 n 42 ALA 42 A THR 43 n 43 THR 43 A ASN 44 n 44 ASN 44 A TYR 45 n 45 TYR 45 A ASN 46 n 46 ASN 46 A ALA 47 n 47 ALA 47 A GLY 48 n 48 GLY 48 A ASP 49 n 49 ASP 49 A ARG 50 n 50 ARG 50 A SER 51 n 51 SER 51 A THR 52 n 52 THR 52 A ASP 53 n 53 ASP 53 A TYR 54 n 54 TYR 54 A GLY 55 n 55 GLY 55 A ILE 56 n 56 ILE 56 A PHE 57 n 57 PHE 57 A GLN 58 n 58 GLN 58 A ILE 59 n 59 ILE 59 A ASN 60 n 60 ASN 60 A SER 61 n 61 SER 61 A ARG 62 n 62 ARG 62 A TYR 63 n 63 TYR 63 A TRP 64 n 64 TRP 64 A CYS 65 n 65 CYS 65 A ASN 66 n 66 ASN 66 A ASP 67 n 67 ASP 67 A GLY 68 n 68 GLY 68 A LYS 69 n 69 LYS 69 A THR 70 n 70 THR 70 A PRO 71 n 71 PRO 71 A GLY 72 n 72 GLY 72 A ALA 73 n 73 ALA 73 A VAL 74 n 74 VAL 74 A ASN 75 n 75 ASN 75 A ALA 76 n 76 ALA 76 A CYS 77 n 77 CYS 77 A HIS 78 n 78 HIS 78 A LEU 79 n 79 LEU 79 A SER 80 n 80 SER 80 A CYS 81 n 81 CYS 81 A SER 82 n 82 SER 82 A ALA 83 n 83 ALA 83 A LEU 84 n 84 LEU 84 A LEU 85 n 85 LEU 85 A GLN 86 n 86 GLN 86 A ASP 87 n 87 ASP 87 A ASN 88 n 88 ASN 88 A ILE 89 n 89 ILE 89 A ALA 90 n 90 ALA 90 A ASP 91 n 91 ASP 91 A ALA 92 n 92 ALA 92 A VAL 93 n 93 VAL 93 A ALA 94 n 94 ALA 94 A CYS 95 n 95 CYS 95 A ALA 96 n 96 ALA 96 A LYS 97 n 97 LYS 97 A ARG 98 n 98 ARG 98 A VAL 99 n 99 VAL 99 A VAL 100 n 100 VAL 100 A ARG 101 n 101 ARG 101 A ASP 102 n 102 ASP 102 A PRO 103 n 103 PRO 103 A GLN 104 n 104 GLN 104 A GLY 105 n 105 GLY 105 A ILE 106 n 106 ILE 106 A ARG 107 n 107 ARG 107 A ALA 108 n 108 ALA 108 A TRP 109 n 109 TRP 109 A VAL 110 n 110 VAL 110 A ALA 111 n 111 ALA 111 A TRP 112 n 112 TRP 112 A ARG 113 n 113 ARG 113 A ASN 114 n 114 ASN 114 A HIS 115 n 115 HIS 115 A CYS 116 n 116 CYS 116 A GLN 117 n 117 GLN 117 A ASN 118 n 118 ASN 118 A ARG 119 n 119 ARG 119 A ASP 120 n 120 ASP 120 A VAL 121 n 121 VAL 121 A ARG 122 n 122 ARG 122 A GLN 123 n 123 GLN 123 A TYR 124 n 124 TYR 124 A VAL 125 n 125 VAL 125 A GLN 126 n 126 GLN 126 A GLY 127 n 127 GLY 127 A CYS 128 n 128 CYS 128 A GLY 129 n 129 GLY 129 A VAL 130 n 130 VAL 130 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 6.38 0.80 106.30 112.68 A A A CD1 CG CD2 TRP TRP TRP 28 28 28 N 1 -5.90 0.80 107.30 101.40 A A A CE2 CD2 CG TRP TRP TRP 28 28 28 N 1 6.39 0.80 106.30 112.69 A A A CD1 CG CD2 TRP TRP TRP 34 34 34 N 1 -5.55 0.80 107.30 101.75 A A A CE2 CD2 CG TRP TRP TRP 34 34 34 N 1 3.93 0.50 120.30 124.23 A A A NE CZ NH1 ARG ARG ARG 41 41 41 N 1 7.05 0.80 106.30 113.35 A A A CD1 CG CD2 TRP TRP TRP 64 64 64 N 1 -8.87 1.30 127.00 118.13 A A A CB CG CD1 TRP TRP TRP 64 64 64 N 1 -5.51 0.80 107.30 101.79 A A A CE2 CD2 CG TRP TRP TRP 64 64 64 N 1 6.21 0.90 133.90 140.11 A A A CG CD2 CE3 TRP TRP TRP 64 64 64 N 1 -3.01 0.50 120.30 117.29 A A A NE CZ NH2 ARG ARG ARG 98 98 98 N 1 3.28 0.50 120.30 123.58 A A A NE CZ NH1 ARG ARG ARG 101 101 101 N 1 -4.62 0.50 120.30 115.68 A A A NE CZ NH2 ARG ARG ARG 101 101 101 N 1 5.54 0.80 106.30 111.84 A A A CD1 CG CD2 TRP TRP TRP 109 109 109 N 1 -5.42 0.80 107.30 101.88 A A A CE2 CD2 CG TRP TRP TRP 109 109 109 N 1 5.82 0.80 106.30 112.12 A A A CD1 CG CD2 TRP TRP TRP 112 112 112 N 1 -5.01 0.80 107.30 102.29 A A A CE2 CD2 CG TRP TRP TRP 112 112 112 N 1 -3.61 0.50 120.30 116.69 A A A NE CZ NH2 ARG ARG ARG 113 113 113 N 1 4.26 0.50 120.30 124.56 A A A NE CZ NH1 ARG ARG ARG 122 122 122 N 1 A CYS 116 -138.25 -39.60 0.181 0.181 1.77 10.0 1 1.77 10.0 72 1100 0 0 1028 0.012 2.75 1.5 2.0 2.0 2.5 model building X-PLOR refinement X-PLOR phasing X-PLOR LYSOZYME (E.C.3.2.1.17) MUTANT WITH ARG 115 REPLACED BY HIS (R115H) ROLE OF ARG 115 IN THE CATALYTIC ACTION OF HUMAN LYSOZYME. X-RAY STRUCTURE OF HIS 115 AND GLU 115 MUTANTS 1 N N 2 N N A GLU 4 A GLU 4 HELX_P A LEU 15 A LEU 15 1 H1 12 A LEU 25 A LEU 25 HELX_P A SER 36 A SER 36 1 H2 12 A SER 80 A SER 80 HELX_P A LEU 85 A LEU 85 5 H3 6 A ILE 89 A ILE 89 HELX_P A VAL 100 A VAL 100 1 H4 12 A GLN 104 A GLN 104 HELX_P A TRP 109 A TRP 109 5 H5 6 A VAL 110 A VAL 110 HELX_P A CYS 116 A CYS 116 1 H6 7 disulf 2.040 A CYS 6 A SG CYS 6 1_555 A CYS 128 A SG CYS 128 1_555 disulf 1.996 A CYS 30 A SG CYS 30 1_555 A CYS 116 A SG CYS 116 1_555 disulf 2.042 A CYS 65 A SG CYS 65 1_555 A CYS 81 A SG CYS 81 1_555 disulf 2.007 A CYS 77 A SG CYS 77 1_555 A CYS 95 A SG CYS 95 1_555 HYDROLASE(O-GLYCOSYL) HYDROLASE(O-GLYCOSYL) LYSC_HUMAN UNP 1 1 P61626 MKALIVLGLVLLSVTVQGKVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSR YWCNDGKTPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV 19 148 133L 1 130 P61626 A 1 1 130 1 ARG CONFLICT HIS 115 133L A P61626 UNP 133 115 2 3 2 anti-parallel anti-parallel anti-parallel parallel A LYS 1 A LYS 1 A PHE 3 A PHE 3 A TYR 38 A TYR 38 A THR 40 A THR 40 A ALA 42 A ALA 42 A ASN 46 A ASN 46 A SER 51 A SER 51 A GLY 55 A GLY 55 A GLN 58 A GLN 58 A SER 61 A SER 61 A ARG 62 A ARG 62 A ASN 66 A ASN 66 A VAL 74 A VAL 74 A LEU 79 A LEU 79 19 P 21 21 21